{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:58:09Z","timestamp":1775008689771,"version":"3.50.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Synthese"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11229-017-1642-2","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T08:47:55Z","timestamp":1512031675000},"page":"4363-4390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Philosophers on drugs"],"prefix":"10.1007","volume":"196","author":[{"given":"Bennett","family":"Holman","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"1642_CR1","volume-title":"Overdosed America","author":"J Abramson","year":"2004","unstructured":"Abramson, J. (2004). Overdosed America. New York: Harper Collins."},{"key":"1642_CR2","first-page":"F1","volume":"24","author":"L Altman","year":"1999","unstructured":"Altman, L. (1999). Inside medical journals, a rising quest for profits. New York Times, 24, F1.","journal-title":"New York Times"},{"key":"1642_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0735-1097(83)80382-9","volume":"2","author":"J Anderson","year":"1983","unstructured":"Anderson, J., Lutz, J., & Allison, S. (1983). Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia. Journal of the American College of Cardiology, 2, 105\u2013114.","journal-title":"Journal of the American College of Cardiology"},{"key":"1642_CR4","doi-asserted-by":"publisher","first-page":"112B","DOI":"10.1016\/0002-9149(84)90514-9","volume":"53","author":"J Anderson","year":"1984","unstructured":"Anderson, J., Stewart, J., & Crevey, B. (1984). A proposal for the clinical use of Flecainide. American Journal of Cardiology, 53, 112B\u2013119B.","journal-title":"American Journal of Cardiology"},{"key":"1642_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/0002-9149(81)91003-1","volume":"47","author":"JL Anderson","year":"1981","unstructured":"Anderson, J. L., Stewart, J. R., Perry, B. A., Van Hamersveld, D. D., Johnson, T. A., & Pitt, B. (1981a). Oral flecainide acetate for elimination of ventricular arrhythmias in man. The American Journal of Cardiology, 47, 482.","journal-title":"The American Journal of Cardiology"},{"issue":"9","key":"1642_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJM198108273050901","volume":"305","author":"JL Anderson","year":"1981","unstructured":"Anderson, J. L., Stewart, J. R., Perry, B. A., Van Hamersveld, D. D., Johnson, T. A., Conard, G. J., et al. (1981b). Oral flecainide acetate for the treatment of ventricular arrhythmias. New England Journal of Medicine, 305(9), 473\u2013477.","journal-title":"New England Journal of Medicine"},{"key":"1642_CR7","volume-title":"The truth about drug companies","author":"M Angell","year":"2004","unstructured":"Angell, M. (2004). The truth about drug companies. New York, NY: Random House Press."},{"key":"1642_CR8","volume-title":"Powerful medicines: The benefits, risks, and costs of prescription drugs","author":"J Avorn","year":"2004","unstructured":"Avorn, J. (2004). Powerful medicines: The benefits, risks, and costs of prescription drugs. New York, NY: Alfred A. Knopf."},{"key":"1642_CR9","volume-title":"Side effects","author":"A Bass","year":"2008","unstructured":"Bass, A. (2008). Side effects. Chapel Hill, NC: Algonquin Books."},{"key":"1642_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02691720601125472","volume":"21","author":"J Biddle","year":"2007","unstructured":"Biddle, J. (2007). Lessons from the Vioxx debacle: What the privatization of science can teach us about social epistemology. Social Epistemology, 21, 21\u201339.","journal-title":"Social Epistemology"},{"key":"1642_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/01.CIR.69.2.250","volume":"69","author":"J Bigger Jr","year":"1984","unstructured":"Bigger, J, Jr., Fleiss, J., Kleiger, R., Miller, J., & Rolnitzky, L. (1984). The relationship between ventricular arrhythmias, left ventricular dysfunction and mortality in the two years after myocardial infarction. Circulation, 69, 250\u2013258.","journal-title":"Circulation"},{"key":"1642_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11098-016-0682-7","volume":"174","author":"LK Bright","year":"2017","unstructured":"Bright, L. K. (2017). On fraud. Philosophical Studies, 174, 291\u2013310.","journal-title":"Philosophical Studies"},{"key":"1642_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/acprof:oso\/9780199574131.003.0003","volume-title":"Causality in the sciences","author":"A Broadbent","year":"2011","unstructured":"Broadbent, A. (2011). Inferring causation in epidemiology: Mechanisms, black boxes, and contrasts. In P. Illari McKay, F. Russo, & J. Williamson (Eds.), Causality in the sciences (pp. 45\u201369). Oxford: Oxford University Press."},{"key":"1642_CR14","volume-title":"Hooked: Ethics, the medical profession, and the pharmaceutical industry","author":"H Brody","year":"2007","unstructured":"Brody, H. (2007). Hooked: Ethics, the medical profession, and the pharmaceutical industry. Lanham, MD: Rowman and Littlefield."},{"key":"1642_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-94-009-8270-3_9","volume-title":"The evaluation of new antiarrhythmic drugs","author":"RW Campbell","year":"1981","unstructured":"Campbell, R. W. (1981). Evaluation of antiarrhythmic drugs: Should the Lown classification be used. In E. N. J. Morganroth (Ed.), The evaluation of new antiarrhythmic drugs (pp. 113\u2013122). Boston, MA: Martinus Nijhoff Publishers."},{"key":"1642_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1745855207005029","volume":"2","author":"N Cartwright","year":"2007","unstructured":"Cartwright, N. (2007). Are RCTs the gold standard? Biosocieties, 2, 11\u201320.","journal-title":"Biosocieties"},{"key":"1642_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/CBO9780511812880.016","volume-title":"Philosophy of the social sciences. Philosophical theory and scientific practice","author":"N Cartwright","year":"2009","unstructured":"Cartwright, N. (2009). What is this thing called \u201cefficacy\u201d? In C. Mantzavinos (Ed.), Philosophy of the social sciences. Philosophical theory and scientific practice (pp. 185\u2013206). Cambridge: Cambridge University Press."},{"key":"1642_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11098-009-9450-2","volume":"147","author":"N Cartwright","year":"2010","unstructured":"Cartwright, N. (2010). What are randomized controlled trials good for? Philosophical Studies, 147, 59\u201370.","journal-title":"Philosophical Studies"},{"key":"1642_CR19","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/S0140-6736(11)60563-1","volume":"377","author":"N Cartwright","year":"2011","unstructured":"Cartwright, N. (2011). A philosophers view of the long road from RCTS to effectiveness. The Lancet, 377, 1400\u20131401.","journal-title":"The Lancet"},{"key":"1642_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:osobl\/9780199841608.001.0001","volume-title":"Evidence-based policy","author":"N Cartwright","year":"2012","unstructured":"Cartwright, N., & Hardie, J. (2012). Evidence-based policy. Oxford: Oxford University Press."},{"key":"1642_CR21","first-page":"291","volume-title":"Evidence, inference and enquiry","author":"N Cartwright","year":"2011","unstructured":"Cartwright, N., & Stegenga, J. (2011). A theory of evidence for evidence-based policy. In P. Dawid, W. Twinning, & M. Vasilaki (Eds.), Evidence, inference and enquiry (pp. 291\u2013322). Oxford: Oxford University Press."},{"key":"1642_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"CAST Investigators","year":"1989","unstructured":"CAST Investigators. (1989). Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine, 321, 406\u201312.","journal-title":"New England Journal of Medicine"},{"key":"1642_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJM199207233270403","volume":"327","author":"CAST II Investigators","year":"1992","unstructured":"CAST II Investigators. (1992). Effect of the antiarrhythmic agent Moricizine on survival after myocardial infarction. New England Journal of Medicine, 327, 227\u2013233.","journal-title":"New England Journal of Medicine"},{"key":"1642_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11245-013-9220-9","volume":"33","author":"B Clarke","year":"2014","unstructured":"Clarke, B., Gillies, D., Illari, P., Russo, F., & Williamson, J. (2014). Mechanisms and the evidence hierarchy. Topoi, 33, 339\u2013360.","journal-title":"Topoi"},{"key":"1642_CR25","first-page":"760","volume":"67","author":"CPC (Council on Pharmacy and Chemistry)","year":"1914","unstructured":"CPC (Council on Pharmacy and Chemistry). (1914). The hypophosphite fallacy. JAMA, 67, 760\u2013762.","journal-title":"JAMA"},{"key":"1642_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/08989621.2016.1153971","volume":"23","author":"L Cosgrove","year":"2016","unstructured":"Cosgrove, L., Vannoy, S., Mintzes, B., & Shaughnessy, A. F. (2016). Under the influence: The interplay among industry, publishing, and drug regulation. Accountability in Research, 23, 257\u2013279.","journal-title":"Accountability in Research"},{"key":"1642_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0167-5273(93)90279-P","volume":"40","author":"A Cowley","year":"1993","unstructured":"Cowley, A., Skene, A., Stainer, K., & Hampton, J. (1993). The effect of Lorcainide on arrhythmias and survival in patients with acute myocardial infarction: An example of publication bias. International Journal of Cardiology, 40, 161\u2013166.","journal-title":"International Journal of Cardiology"},{"key":"1642_CR28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3109\/01443618109067366","volume":"1","author":"P Crowley","year":"1981","unstructured":"Crowley, P. (1981). Corticosteroids in pregnancy: The benefits outweigh the cost. Journal of Obstetrics and Gynaecology, 1, 1147\u2013150.","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"1642_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11229-011-0011-9","volume":"187","author":"S Dragulinescu","year":"2012","unstructured":"Dragulinescu, S. (2012). On \u2018Stabilising\u2019 medical mechanisms, truth-makers and epistemic causality: A critique to Williamson and Russo\u2019s approach. Synthese, 187, 785\u2013800.","journal-title":"Synthese"},{"key":"1642_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12136-016-0292-1","volume":"32","author":"S Dragulinescu","year":"2017","unstructured":"Dragulinescu, S. (2017). Mechanisms and difference-making. Acta Analytica, 32, 29\u201354.","journal-title":"Acta Analytica"},{"key":"1642_CR31","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0002-9149(81)90331-3","volume":"48","author":"HJ Duff","year":"1981","unstructured":"Duff, H. J., Roden, D. M., Maffucci, R. J., Vesper, B. S., Conard, G. J., Higgins, S. B., et al. (1981). Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. The American Journal of Cardiology, 48, 1133\u20131140.","journal-title":"The American Journal of Cardiology"},{"key":"1642_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/01.CIR.62.1.181","volume":"62","author":"HJ Duff","year":"1980","unstructured":"Duff, H. J., Roden, D. M., & Woosley, R. L. (1980). Abolition of resistant ventricular arrhythmias by twice daily dosing with flecainide. Circulation, 62, 181.","journal-title":"Circulation"},{"key":"1642_CR33","volume-title":"White coat black hat: Adventures on the dark side of medicine","author":"C Elliott","year":"2010","unstructured":"Elliott, C. (2010). White coat black hat: Adventures on the dark side of medicine. Boston: Beacon Press."},{"key":"1642_CR34","unstructured":"Epstein, S. (1996). Impure science. Aids and the politics of knowledge. Berkeley-Los Angeles: University of California Press."},{"key":"1642_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.shpsa.2014.03.006","volume":"47","author":"M Fern\u00e1ndez Pinto","year":"2014","unstructured":"Fern\u00e1ndez Pinto, M. (2014). Philosophy of science for globalized privatization: Uncovering some limitations of critical contextual empiricism. Studies in History and Philosophy of Science Part A, 47, 10\u201317.","journal-title":"Studies in History and Philosophy of Science Part A"},{"key":"1642_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1385\/1-59259-012-8:149","volume-title":"Platinum-based drugs in cancer therapy","author":"D Fink","year":"2000","unstructured":"Fink, D., & Howell, I. (2000). How does Cisplatin kill cells? In I. Kelland & N. Farrell (Eds.), Platinum-based drugs in cancer therapy (pp. 149\u2013167). Totowa: Humana Press."},{"key":"1642_CR37","unstructured":"Fuller, J. (in press). The confounding question of confounding causes in randomized trials. British Journal for the Philosophy of Science."},{"key":"1642_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.shpsc.2015.02.007","volume":"51","author":"M Gonz\u00e1lez-Moreno","year":"2015","unstructured":"Gonz\u00e1lez-Moreno, M., Saborido, C., & Teira, D. (2015). Disease-mongering through clinical trials. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 51, 11\u201318.","journal-title":"Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences"},{"key":"1642_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/0198238207.001.0001","volume-title":"Knowledge in a social world","author":"A Goldman","year":"1999","unstructured":"Goldman, A. (1999). Knowledge in a social world. New York, NY: Oxford University Press."},{"key":"1642_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0002-9149(82)90307-1","volume":"50","author":"T Graboys","year":"1982","unstructured":"Graboys, T., Lown, B., Podrid, P. J., & DeSilva, R. (1982). Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. The American Journal of Cardiology, 50, 437\u2013443.","journal-title":"The American Journal of Cardiology"},{"issue":"3","key":"1642_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1527-2001.2004.tb01303.x","volume":"19","author":"HE Grasswick","year":"2004","unstructured":"Grasswick, H. E. (2004). Individuals-in-communities: The search for a Feminist model of epistemic subjects. Hypatia, 19(3), 85\u2013120.","journal-title":"Hypatia"},{"key":"1642_CR42","doi-asserted-by":"crossref","DOI":"10.1525\/9780520951815","volume-title":"Pharmageddon","author":"D Healy","year":"2012","unstructured":"Healy, D. (2012). Pharmageddon. Berkeley: University of California Press."},{"key":"1642_CR43","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1001\/jama.1989.03430210079035","volume":"262","author":"L Hine","year":"1989","unstructured":"Hine, L., Laird, N., Hewitt, P., & Chalmers, T. (1989). Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. JAMA, 262, 3037\u20133040.","journal-title":"JAMA"},{"key":"1642_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/0002-9149(81)91004-3","volume":"47","author":"M Hodges","year":"1981","unstructured":"Hodges, M., Haugland, J. M., Granrud, G., Asinger, R. W., Mikell, F. L., & Krejci, J. (1981). Flecainide acetate, a new antiarrhythmic agent: Dose-ranging and efficacy study. The American Journal of Cardiology, 47, 482.","journal-title":"The American Journal of Cardiology"},{"issue":"5","key":"1642_CR45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.CIR.65.5.879","volume":"65","author":"M Hodges","year":"1982","unstructured":"Hodges, M., Haugland, J. M., Granrud, G., Conard, G. J., Asinger, R. W., Mikell, F. L., et al. (1982). Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Circulation, 65(5), 879\u2013885.","journal-title":"Circulation"},{"key":"1642_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/978-94-009-8270-3_2","volume-title":"The evaluation of new antiarrhythmic drugs","author":"BF Hoffman","year":"1981","unstructured":"Hoffman, B. F. (1981). Relationship between effects on cardiac electrophysiology and antiarrhythmic efficacy. In J. Morganroth, E. N. Moore, L. S. Dreifus, & E. L. Michelson (Eds.), The evaluation of new antiarrhythmic drugs (pp. 5\u201316). Boston, MA: Martinus Nijhoff Publishers."},{"key":"1642_CR47","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1086\/683817","volume":"82","author":"B Holman","year":"2015","unstructured":"Holman, B. (2015). Why most sugar pills are not placebos. Philosophy of Science, 82, 1330\u20131343.","journal-title":"Philosophy of Science"},{"key":"1642_CR48","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1086\/683344","volume":"82","author":"B Holman","year":"2015","unstructured":"Holman, B., & Bruner, J. (2015). The problem of intransigently biased agents. Philosophy of Science, 82, 956\u2013968.","journal-title":"Philosophy of Science"},{"key":"1642_CR49","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1086\/694037","volume":"84","author":"B Holman","year":"2017","unstructured":"Holman, B., & Bruner, J. P. (2017). Experimentation by industrial selection. Philosophy of Science, 84, 1008\u20131019.","journal-title":"Philosophy of Science"},{"key":"1642_CR50","volume-title":"The philosophy of evidenced-based medicine","author":"J Howick","year":"2012","unstructured":"Howick, J. (2012). The philosophy of evidenced-based medicine. West Sussex: British Medical Journal Books."},{"key":"1642_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/02698595.2011.574856","volume":"25","author":"PM Illari","year":"2011","unstructured":"Illari, P. M. (2011). Mechanistic evidence: Disambiguating the Russo\u2013Williamson thesis. International Studies in the Philosophy of Science, 25, 139\u2013157.","journal-title":"International Studies in the Philosophy of Science"},{"key":"1642_CR52","first-page":"48","volume-title":"Routledge companion to philosophy of medicine","author":"P Illari","year":"2017","unstructured":"Illari, P. (2017). Mechanisms in medicine. In M. Solomon, J. Simon, & H. Kincaid (Eds.), Routledge companion to philosophy of medicine (pp. 48\u201357). New York, NY: Routledge."},{"key":"1642_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-319-18600-9_7","volume-title":"Empirical philosophy of science: Introducing qualitative methods into philosophy of science","author":"S Jukola","year":"2015","unstructured":"Jukola, S. (2015). Longino\u2019s theory of objectivity and commercialized research. In S. Wagenknecht, N. Nersessian, & H. Andersen (Eds.), Empirical philosophy of science: Introducing qualitative methods into philosophy of science (pp. 127\u2013143). Berlin: Springer."},{"issue":"1","key":"1642_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/JRS-160671","volume":"28","author":"JN Jureidini","year":"2016","unstructured":"Jureidini, J. N., Amsterdam, J. D., & McHenry, L. B. (2016). The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance. International Journal of Risk and Safety in Medicine, 28(1), 33\u201343.","journal-title":"International Journal of Risk and Safety in Medicine"},{"key":"1642_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195300048.001.0001","volume-title":"On the take","author":"J Kassirer","year":"2005","unstructured":"Kassirer, J. (2005). On the take. Oxford: Oxford University Press."},{"key":"1642_CR56","volume-title":"Science in the private interest: Has the lure of profits corrupted medical research?","author":"S Krimsky","year":"2003","unstructured":"Krimsky, S. (2003). Science in the private interest: Has the lure of profits corrupted medical research?. Landham, MD: Rowman and Littlefield."},{"key":"1642_CR57","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/bmj.326.7381.170","volume":"326","author":"J Lenzer","year":"2003","unstructured":"Lenzer, J. (2003). Marketing: Spin doctors soft pedal data on antihypertensives. British Medical Journal, 326, 170.","journal-title":"British Medical Journal"},{"key":"1642_CR58","doi-asserted-by":"crossref","DOI":"10.1515\/9780691209753","volume-title":"Science as social knowledge: Values and objectivity in scientific inquiry","author":"HE Longino","year":"1990","unstructured":"Longino, H. E. (1990). Science as social knowledge: Values and objectivity in scientific inquiry. Princeton, NJ: Princeton University Press."},{"key":"1642_CR59","doi-asserted-by":"publisher","DOI":"10.1515\/9780691187013","volume-title":"The fate of knowledge","author":"HE Longino","year":"2002","unstructured":"Longino, H. E. (2002). The fate of knowledge. Princeton, NJ: Princeton University Press."},{"key":"1642_CR60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9149(79)80021-1","volume":"43","author":"B Lown","year":"1979","unstructured":"Lown, B. (1979). Sudden cardiac death: The major challenge confronting contemporary cardiology. The American Journal of Cardiology, 43, 313\u2013328.","journal-title":"The American Journal of Cardiology"},{"key":"1642_CR61","volume-title":"Error and inference: Recent exchanges on experimental reasoning, reliability, and the objectivity and rationality of science","author":"D Mayo","year":"2010","unstructured":"Mayo, D., & Spanos, A. (2010). Error and inference: Recent exchanges on experimental reasoning, reliability, and the objectivity and rationality of science. New York, NY: Cambridge University Press."},{"key":"1642_CR62","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1086\/661777","volume":"78","author":"Connor Mayo-Wilson","year":"2011","unstructured":"Mayo-Wilson, Connor, Zollman, Kevin J., & Danks, David. (2011). The independence thesis: When individual and social epistemology diverge. Philosophy of Science, 78, 653\u2013677.","journal-title":"Philosophy of Science"},{"key":"1642_CR63","unstructured":"Merrick, T. (forthcoming). From \u2018Intersex\u2019 to \u2018DSD\u2019: A case of epistemic injustice. Synthese. http:\/\/doi.org.ssl.access.yonsei.ac.kr:8080\/10.1007\/s11229-017-1327-x"},{"key":"1642_CR64","volume-title":"Deadly medicines: Why tens of thousands of heart patients died in America\u2019s worst drug disaster","author":"T Moore","year":"1995","unstructured":"Moore, T. (1995). Deadly medicines: Why tens of thousands of heart patients died in America\u2019s worst drug disaster. New York, NY: Simon and Schuster."},{"key":"1642_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-009-8270-3","volume-title":"The evaluation of new antiarrhythmic drugs","author":"J Morganroth","year":"1981","unstructured":"Morganroth, J. (1981a). The evaluation of new antiarrhythmic drugs. Boston, MA: Martinus Nijhoff Publishers."},{"key":"1642_CR66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-94-009-8270-3_8","volume-title":"The evaluation of new antiarrhythmic drugs","author":"J Morganroth","year":"1981","unstructured":"Morganroth, J. (1981b). Long-term ambulatory electrocardiographic recording in the determination of efficacy of new antiarrhythmic drugs. In E. N. J. Morganroth (Ed.), The evaluation of new antiarrhythmic drugs (pp. 103\u2013112). Boston, MA: Martinus Nijhoff Publishers."},{"key":"1642_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/978-1-4613-3876-5_6","volume-title":"Sudden cardiac death and congestive heart failure: Diagnosis and treatment","author":"J Morganroth","year":"1983","unstructured":"Morganroth, J. (1983). Study design for patients with chronic ventricular ectopy: Determination of efficacy and tolerance. In J. Morganroth & E. Moore (Eds.), Sudden cardiac death and congestive heart failure: Diagnosis and treatment (pp. 64\u201373). Boston, MA: Martinus Nijhoff Publishers."},{"key":"1642_CR68","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jama.1984.03350050061030","volume":"252","author":"J Morganroth","year":"1984","unstructured":"Morganroth, J. (1984). Premature ventricular complex. JAMA, 252, 673\u2013676.","journal-title":"JAMA"},{"key":"1642_CR69","volume-title":"Selling sickness: How the world\u2019s biggest pharmaceutical companies are turning us all into patients","author":"R Moynihan","year":"2006","unstructured":"Moynihan, R., & Cassels, A. (2006). Selling sickness: How the world\u2019s biggest pharmaceutical companies are turning us all into patients. New York, NY: Nation Books."},{"key":"1642_CR70","unstructured":"Mukharji, J., Rude, R., Poole, K., Croft, C., Thomas, L., Braunwald, E., & Cooperating Investigators . (1982). Late sudden death following acute myocardial infarction: Importance of combined presence of repetitive ventricular ectopy and left ventricular dysfunction. Clinical Research, 30, 108A."},{"key":"1642_CR71","volume-title":"Criticism and the growth knowledge","author":"K Popper","year":"1970","unstructured":"Popper, K. (1970). Normal science and its dangers. In Imre Lakatos & Alan Musgrave (Eds.), Criticism and the growth knowledge. Cambridge: Cambridge University Press."},{"key":"1642_CR72","unstructured":"Robinson, M. (2014). Neuro-innovation: Translational science, ethics and the financialization of health (Doctoral Dissertation, Princeton University)."},{"key":"1642_CR73","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM198004173021601","volume":"302","author":"D Roden","year":"1980","unstructured":"Roden, D., Reele, S., Higgins, S., Mayol, R., Gammans, R., Oates, J., et al. (1980). Total suppression of ventricular arrhythmias by encainide: Pharmacokinetic and electrocardiographic characteristics. New England Journal of Medicine, 302, 877\u2013882.","journal-title":"New England Journal of Medicine"},{"key":"1642_CR74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/02698590701498084","volume":"21","author":"F Russo","year":"2007","unstructured":"Russo, F., & Williamson, J. (2007). Interpreting causality in the health sciences. International Studies in the Philosophy of Science, 21, 157\u2013170.","journal-title":"International Studies in the Philosophy of Science"},{"key":"1642_CR75","first-page":"563","volume":"33","author":"F Russo","year":"2011","unstructured":"Russo, F., & Williamson, J. (2011). Epistemic causality and evidence-based medicine. History and Philosophy of the Life Sciences, 33, 563\u2013581.","journal-title":"History and Philosophy of the Life Sciences"},{"issue":"9","key":"1642_CR76","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1371\/journal.pmed.0040286","volume":"4","author":"S Sismondo","year":"2007","unstructured":"Sismondo, S. (2007). Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine, 4(9), e286.","journal-title":"PLoS Medicine"},{"key":"1642_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/0306312708101047","volume":"39","author":"S Sismondo","year":"2009","unstructured":"Sismondo, S. (2009). Ghosts in the machine: Publication planning in the medical sciences. Social Studies of Science, 39, 171\u2013198.","journal-title":"Social Studies of Science"},{"key":"1642_CR78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-94-024-0979-6_4","volume-title":"Philosophical issues in pharmaceutics","author":"S Sismondo","year":"2017","unstructured":"Sismondo, S. (2017). Hegemony of knowledge and pharmaceutical industry strategy. In D. Ho (Ed.), Philosophical issues in pharmaceutics (pp. 47\u201363). Dordrecht: Springer."},{"key":"1642_CR79","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/6296.001.0001","volume-title":"Social empiricism","author":"M Solomon","year":"2001","unstructured":"Solomon, M. (2001). Social empiricism. Cambridge, MA: MIT Press."},{"key":"1642_CR80","first-page":"60","volume-title":"Philosophical issues in psychiatry III: The nature and sources of historical change","author":"M Solomon","year":"2015","unstructured":"Solomon, M. (2015a). Expert disagreement and medical authority. In Kenneth S. Kendler & Josef Parnas (Eds.), Philosophical issues in psychiatry III: The nature and sources of historical change (pp. 60\u201372). Oxford: Oxford University Press."},{"key":"1642_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780198732617.001.0001","volume-title":"Making medical knowledge","author":"M Solomon","year":"2015","unstructured":"Solomon, M. (2015b). Making medical knowledge. Oxford: Oxford University Press."},{"key":"1642_CR82","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11245-013-9189-4","volume":"33","author":"J Stegenga","year":"2014","unstructured":"Stegenga, J. (2014). Down with the hierarchies. Topoi, 33, 313\u2013322.","journal-title":"Topoi"},{"key":"1642_CR83","volume-title":"Evidence-based medicine: How to practice and teach EBM","author":"S Straus","year":"2005","unstructured":"Straus, S., Richardson, W., Glasziou, P., & Haynes, R. (2005). Evidence-based medicine: How to practice and teach EBM (3rd ed.). Edinburgh: Churchill Livingstone.","edition":"3"},{"key":"1642_CR84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1745-6215-13-136","volume":"13","author":"SS Vedula","year":"2012","unstructured":"Vedula, S. S., Goldman, P. S., Rona, I. J., Greene, T. M., & Dickersin, K. (2012). Implementation of a publication strategy in the context of reporting biases: A case study based on new documents from Neurontin\u00ae litigation. Trials, 13, 136.","journal-title":"Trials"},{"key":"1642_CR85","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/01.CIR.65.5.886","volume":"65","author":"V Velebit","year":"1982","unstructured":"Velebit, V., Podrid, P., Lown, B., Cohen, B., & Graboys, T. (1982). Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation, 65, 886\u2013894.","journal-title":"Circulation"},{"key":"1642_CR86","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/hypa.12052","volume":"29","author":"MJ Walker","year":"2014","unstructured":"Walker, M. J., & Rogers, W. (2014). What can feminist epistemology do for surgery? Hypatia, 29, 404\u2013421.","journal-title":"Hypatia"},{"key":"1642_CR87","volume-title":"Anatomy of an epidemic: Magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America","author":"R Whitaker","year":"2010","unstructured":"Whitaker, R. (2010). Anatomy of an epidemic: Magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America. New York, NY: Crown Publishers."},{"key":"1642_CR88","first-page":"105","volume":"21","author":"J White","year":"2010","unstructured":"White, J., & Bero, L. A. (2010). Corporate manipulation of research: Strategies are similar across five industries. Stanford Law and Policy Review, 21, 105.","journal-title":"Stanford Law and Policy Review"},{"key":"1642_CR89","doi-asserted-by":"crossref","unstructured":"Winkle, R., Mason, J., Griffin, J., & Ross, D. (1981). Malignant ventricular tachyarrhythmias associated with the use of encainide. American Heart Journal, 102, 857\u2013864.","DOI":"10.1016\/0002-8703(81)90036-3"},{"key":"1642_CR90","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/clpt.1990.75","volume":"47","author":"R Woosley","year":"1990","unstructured":"Woosley, R. (1990). CAST: Implications for drug development. Clinical Pharmacology and Therapeutics, 47, 553\u2013556.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"1642_CR91","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1086\/341855","volume":"69","author":"J Worrall","year":"2002","unstructured":"Worrall, J. (2002). What evidence in evidence-based medicine? Proceedings of the Philosophy of Science Association, 69, S316\u2013S330.","journal-title":"Proceedings of the Philosophy of Science Association"},{"key":"1642_CR92","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1747-9991.2007.00106.x","volume":"2","author":"J Worrall","year":"2007","unstructured":"Worrall, J. (2007a). Evidence in medicine and evidence-based medicine. Philosophy Compass, 2, 981\u20131022.","journal-title":"Philosophy Compass"},{"key":"1642_CR93","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/bjps\/axm024","volume":"58","author":"J Worrall","year":"2007","unstructured":"Worrall, J. (2007b). Why there\u2019s no cause to randomize. British Journal for the Philosophy of Science, 58, 451\u2013488.","journal-title":"British Journal for the Philosophy of Science"},{"key":"1642_CR94","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1365-2753.2010.01400.x","volume":"16","author":"J Worrall","year":"2010","unstructured":"Worrall, J. (2010). Evidence: Philosophy of science meets medicine. Journal of Evaluation in Clinical Practice, 16, 356\u2013362.","journal-title":"Journal of Evaluation in Clinical Practice"}],"container-title":["Synthese"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11229-017-1642-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11229-017-1642-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11229-017-1642-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T06:52:17Z","timestamp":1603435937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11229-017-1642-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":94,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1007\/s11229-017-1642-2","relation":{},"ISSN":["0039-7857","1573-0964"],"issn-type":[{"value":"0039-7857","type":"print"},{"value":"1573-0964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]},"assertion":[{"value":"22 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}